Vaccitech Limited   Report issue

For profit Phase 2
Founded: Oxford United Kingdom (2016)

Organization Overview

First Clinical Trial
2017
NCT03277456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Vaccitech Limited | Vaccitech (UK) Limited